Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
2
29%
Ph early_phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

not_yet_recruiting114%
completed343%
recruiting114%
unknown229%

Recent Activity

1 active trials
Showing 5 of 7
recruiting

Oscillometry and Machine Learning Approaches

NCT07447596
not_yet_recruiting

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

NCT06356623
completedphase_4

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

NCT01056822
unknownnot_applicable

Verify the Effectiveness rTMS Using MEG

NCT01874444
completed

Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

NCT01085474
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07447596

Oscillometry and Machine Learning Approaches

Recruiting
NCT06356623

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

Not Yet Recruiting
NCT01056822Phase 4

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

Completed
NCT01874444Not Applicable

Verify the Effectiveness rTMS Using MEG

Unknown
NCT01085474

Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

Completed
NCT00620152Not Applicable

Nutrition Study for School Age Children

Completed
NCT00739544Early Phase 1

Chronic Pain After Operation for Breast Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
7